Affordable Access

Publisher Website

Oxidized phospholipids in control of inflammation and endothelial barrier

Authors
Journal
Translational Research
1931-5244
Publisher
Elsevier
Publication Date
Volume
153
Issue
4
Identifiers
DOI: 10.1016/j.trsl.2008.12.005
Disciplines
  • Biology
  • Design
  • Medicine

Abstract

The levels of circulating oxidized phospholipids (OxPLs) become increased in chronic and acute pathologic conditions such as hyperlipidemia, atherosclerosis, increased intimamedia thickness in the patients with systemic Lupus erythematosus, vascular balloon injury, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS). These pathologies are associated with inflammation and activation of endothelial cells. Depending on the biological context and the specific group of phospholipid oxidation products, OxPL may exhibit both proinflammatory and anti-inflammatory effects. This review will summarize the data showing a dual role of OxPL in modulation of chronic and acute inflammation as well as OxPL effects on pulmonary endothelial permeability. Recent reports show protective effects of OxPL in the models of endotoxin and ventilator-induced ALI and suggest a potential for using OxPL-derived cyclopenthenone-containing compounds with barrier-protective properties for drug design. These compounds may represent a new group of therapeutic agents for the treatment of lung syndromes associated with acute inflammation and lung vascular leak.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Afadin controls p120-catenin-ZO-1 interactions lea...

on Journal of Cellular Physiology May 2012

Tiam1 and betaPIX mediate Rac-dependent endothelia...

on Journal of Cellular Physiology June 2007

Epoxycyclopentenone-containing oxidized phospholip...

on Circulation Research Oct 29, 2004

Hydroxyalkenals and oxidized phospholipids modulat...

on Microvascular Research Jan 01, 2012
More articles like this..